504 related articles for article (PubMed ID: 25548132)
1. Inflammation-based scoring is a useful prognostic predictor of pulmonary resection for elderly patients with clinical stage I non-small-cell lung cancer.
Miyazaki T; Yamasaki N; Tsuchiya T; Matsumoto K; Kunizaki M; Taniguchi D; Nagayasu T
Eur J Cardiothorac Surg; 2015 Apr; 47(4):e140-5. PubMed ID: 25548132
[TBL] [Abstract][Full Text] [Related]
2. Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections.
Sienel W; Dango S; Kirschbaum A; Cucuruz B; Hörth W; Stremmel C; Passlick B
Eur J Cardiothorac Surg; 2008 Apr; 33(4):728-34. PubMed ID: 18261918
[TBL] [Abstract][Full Text] [Related]
3. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
[TBL] [Abstract][Full Text] [Related]
4. Ratio of C-reactive protein to albumin is a prognostic factor for operable non-small-cell lung cancer in elderly patients.
Miyazaki T; Yamasaki N; Tsuchiya T; Matsumoto K; Kunizaki M; Kamohara R; Hatachi G; Doi R; Obata T; Nagayasu T
Surg Today; 2017 Jul; 47(7):836-843. PubMed ID: 27853867
[TBL] [Abstract][Full Text] [Related]
5. Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer.
Birim O; Kappetein AP; Bogers AJ
Eur J Cardiothorac Surg; 2005 Nov; 28(5):759-62. PubMed ID: 16157485
[TBL] [Abstract][Full Text] [Related]
6. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of preoperative neutrophil-lymphocyte vs platelet-lymphocyte ratio in primary operable patients with non-small cell lung cancer.
Zhang H; Xia H; Zhang L; Zhang B; Yue D; Wang C
Am J Surg; 2015 Sep; 210(3):526-35. PubMed ID: 26105800
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of the high-sensitivity modified Glasgow prognostic score in patients with resectable non-small cell lung cancer.
Osugi J; Muto S; Matsumura Y; Higuchi M; Suzuki H; Gotoh M
J Cancer Res Ther; 2016; 12(2):945-51. PubMed ID: 27461679
[TBL] [Abstract][Full Text] [Related]
9. Exploring Stage I non-small-cell lung cancer: development of a prognostic model predicting 5-year survival after surgical resection†.
Guerrera F; Errico L; Evangelista A; Filosso PL; Ruffini E; Lisi E; Bora G; Asteggiano E; Olivetti S; Lausi P; Ardissone F; Oliaro A
Eur J Cardiothorac Surg; 2015 Jun; 47(6):1037-43. PubMed ID: 25391390
[TBL] [Abstract][Full Text] [Related]
10. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
[TBL] [Abstract][Full Text] [Related]
11. Validation of the 7th TNM classification for non-small cell lung cancer: a retrospective analysis on prognostic implications for operated node-negative cases.
Bergman P; Brodin D; Lewensohn R; de Petris L
Acta Oncol; 2013 Aug; 52(6):1189-94. PubMed ID: 23215828
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Charlson comorbidity index and Kaplan-Feinstein index in patients with stage I lung cancer after surgical resection.
Wang CY; Lin YS; Tzao C; Lee HC; Huang MH; Hsu WH; Hsu HS
Eur J Cardiothorac Surg; 2007 Dec; 32(6):877-81. PubMed ID: 17920921
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic effect of mediastinal lymph node dissection in patients with stage I non-small cell lung cancer].
Su XD; Wang X; Rong TH; Long H; Fu JH; Lin P; Zhang LJ; Wang SY; Wen ZS; Ma GW
Zhonghua Wai Ke Za Zhi; 2007 Nov; 45(22):1543-5. PubMed ID: 18282391
[TBL] [Abstract][Full Text] [Related]
14. Outcomes and prognostic factors of non-small-cell lung cancer with lymph node involvement treated with induction treatment and surgical resection.
Marulli G; Verderi E; Zuin A; Schiavon M; Battistella L; Perissinotto E; Romanello P; Favaretto AG; Pasello G; Rea F
Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):256-62; discussion 262. PubMed ID: 24824495
[TBL] [Abstract][Full Text] [Related]
15. Significance of the Glasgow Prognostic Score as a prognostic indicator for lung cancer surgery.
Kawashima M; Murakawa T; Shinozaki T; Ichinose J; Hino H; Konoeda C; Tsuchiya T; Murayama T; Nagayama K; Nitadori J; Anraku M; Nakajima J
Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):637-43. PubMed ID: 26269495
[TBL] [Abstract][Full Text] [Related]
16. Performance at preoperative stair-climbing test is associated with prognosis after pulmonary resection in stage I non-small cell lung cancer.
Brunelli A; Pompili C; Berardi R; Mazzanti P; Onofri A; Salati M; Cascinu S; Sabbatini A
Ann Thorac Surg; 2012 Jun; 93(6):1796-800. PubMed ID: 22551844
[TBL] [Abstract][Full Text] [Related]
17. Extent of removal for mediastinal nodal stations for patients with clinical stage I non-small cell lung cancer: effect on outcome.
Jeon HW; Moon MH; Kim KS; Kim YD; Wang YP; Park HJ; Park JK
Thorac Cardiovasc Surg; 2014 Oct; 62(7):599-604. PubMed ID: 24420680
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of pre- and postoperative glasgow prognostic score for patients with non-small cell lung cancer.
Tomita M; Ayabe T; Chosa E; Nakamura K
Anticancer Res; 2014 Jun; 34(6):3137-40. PubMed ID: 24922684
[TBL] [Abstract][Full Text] [Related]
19. The effect of comorbidity on stage-specific survival in resected non-small cell lung cancer patients.
Lüchtenborg M; Jakobsen E; Krasnik M; Linklater KM; Mellemgaard A; Møller H
Eur J Cancer; 2012 Dec; 48(18):3386-95. PubMed ID: 22795582
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil-lymphocyte and platelet-lymphocyte ratios as prognostic factors after stereotactic radiation therapy for early-stage non-small-cell lung cancer.
Cannon NA; Meyer J; Iyengar P; Ahn C; Westover KD; Choy H; Timmerman R
J Thorac Oncol; 2015 Feb; 10(2):280-5. PubMed ID: 25299234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]